Detalhe da pesquisa
1.
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Clin Cancer Res
; 25(14): 4493-4503, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015346
2.
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.
Cancer Cell
; 36(6): 660-673.e11, 2019 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821784